Welcome to Paid Research Studies




  • Condition:   Uveitis
    Intervention:   Other: No specific intervention. Collection of clinical data
    Sponsor:   Hospices Civils de Lyon
    Recruiting

  • Condition:   Uveitis
    Intervention:   Drug: Ustekinumab
    Sponsor:   National Eye Institute (NEI)
    Recruiting

  • Condition:   Uveitis
    Interventions:   Biological: Adalimumab (ADA);   Drug: Conventional immunosuppression (CON)
    Sponsor:   JHSPH Center for Clinical Trials
    Not yet recruiting

  • Condition:   Uveitis
    Intervention:   Drug: ACTH gel
    Sponsors:   Quan Dong Nguyen;   Mallinckrodt
    Recruiting

  • Condition:   Uveitis
    Intervention:  
    Sponsors:   Wroclaw Medical University;   Wrocław University of Science and Technology
    Recruiting

  • Condition:   Uveitis
    Intervention:  
    Sponsor:   National Eye Institute (NEI)
    Recruiting

  • Condition:   Sarcoid Uveitis
    Intervention:   Other: No intervention
    Sponsor:   Hospices Civils de Lyon
    Recruiting

  • Condition:   Noninfectious Uveitis
    Interventions:   Drug: Filgotinib;   Drug: Placebo to match filgotinib;   Drug: Prednisone
    Sponsor:   Gilead Sciences
    Recruiting

  • Condition:   Uveitis
    Interventions:   Drug: Norflo Oro;   Drug: Placebo for Norflo Oro
    Sponsors:   Eye Pharma;   Bascom Palmer Eye Institute
    Recruiting

  • Condition:   Autoimmune Uveitis
    Intervention:   Drug: Corticosteroid Series
    Sponsor:   Assiut University
    Not yet recruiting

  • Condition:   Non-infectious Uveitis
    Intervention:   Drug: PP-001
    Sponsor:   Panoptes Pharma GmbH
    Recruiting

  • Conditions:   Behcet Syndrome;   Uveitis
    Intervention:   Biological: Tocilizumab (TCZ)
    Sponsor:   Wenjie Zheng
    Recruiting

  • Condition:   Non-infectious Uveitis
    Intervention:   Drug: dexamethasone intravitreal implant
    Sponsor:   Allergan
    Recruiting

  • Condition:   Cytomegalovirus Anterior Uveitis
    Interventions:   Drug: Valganciclovir Hydrochloride;   Drug: Ganciclovir Sodium;   Drug: Placebo Oral Tablet;   Drug: Topical placebo
    Sponsors:   University of California, San Francisco;   Huang Pacific Foundation;   Khon Kaen University;   King Chulalongkorn Memorial Hospital;   National Taiwan University;   Francis I. Proctor Foundation
    Not yet recruiting

  • Condition:   Non Infectious Uveitis
    Interventions:   Drug: DE-109 Intravitreal Injections;   Other: Sham Procedure
    Sponsor:   Santen Inc.
    Recruiting

  • Conditions:   Eye Diseases;   Uveitis
    Intervention:   Drug: Abatacept 125 MG/ML Prefilled Syringe
    Sponsors:   Universitaire Ziekenhuizen Leuven;   Ziekenhuis Netwerk Antwerpen (ZNA)
    Recruiting

  • Conditions:   Uveitis;   JIA
    Interventions:   Biological: Adalimumab;   Other: Placebo
    Sponsors:   Nisha Acharya;   Children's Hospital of Philadelphia;   Children's Hospital Medical Center, Cincinnati;   Children's Mercy Hospital Kansas City;   National Eye Institute (NEI);   Great Ormond Street Hospital for Children NHS Foundation Trust;   University Hospitals Bristol NHS Foundation Trust;   Alder Hey Children's NHS Foundation Trust;   Johns Hopkins University;   Children's Hospital Los Angeles;   Seattle Children's Hospital;   Newcastle-upon-Tyne Hospitals NHS Trust;   University Hospital Southampton NHS Foundation Trust;   Sheffield Children's NHS Foundation Trust;   The Royal Children's Hospital
    Not yet recruiting

  • Condition:   Non-infectious Anterior Uveitis
    Interventions:   Drug: ADX-102 Ophthalmic Solution (0.5%);   Drug: Vehicle of ADX-102 Ophthalmic Solution
    Sponsor:   Aldeyra Therapeutics, Inc.
    Recruiting

  • Conditions:   Uveitis, Intermediate;   Uveitis, Posterior
    Intervention:   Drug: Dexamethasone pellet
    Sponsors:   Johns Hopkins University;   Allergan
    Recruiting

  • Conditions:   Behçet Disease;   Uveitis
    Interventions:   Drug: Interferon Alfa-2A;   Drug: Cyclosporine Pill
    Sponsor:   Peking Union Medical College Hospital
    Recruiting

  • Conditions:   Uveitis;   Macular Edema
    Interventions:   Drug: Difluprednate;   Drug: Nepafenac;   Drug: Prednisolone acetate
    Sponsors:   University of California, San Francisco;   Aravind Eye Hospitals, India
    Recruiting

  • Conditions:   Uveitis;   Metformin;   Glucocorticoid
    Interventions:   Drug: Metformin;   Drug: Placebo
    Sponsors:   Tianjin Medical University;   Peking Union Medical College Hospital, Peking University First Hospital and Zhongshan Ophthalmic Center, Sun Yat-sen University
    Not yet recruiting

  • Conditions:   Uveitis, Anterior;   Cytomegalovirus Infections
    Intervention:   Drug: Topical ganciclovir versus oral valganciclovir versus placebo
    Sponsors:   Francis I. Proctor Foundation;   National Taiwan University;   Chulalongkorn University;   Khon Kaen University
    Not yet recruiting

  • Conditions:   Uveitis;   Uveitis Drug-Induced;   Eye Diseases;   Uvea--Diseases
    Intervention:   Drug: Drugs inducing uveitis
    Sponsor:   Groupe Hospitalier Pitie-Salpetriere
    Recruiting

  • Conditions:   Uveitis, Posterior;   Uveitis, Intermediate;   Panuveitis
    Intervention:   Drug: Acthar
    Sponsor:   Mallinckrodt
    Recruiting

  • Conditions:   Uveitis;   Intermediate Uveitis;   Posterior Uveitis;   Panuveitis
    Interventions:   Drug: Intravitreal injection 440mcg;   Drug: Intravitreal injection of sirolimus 880mcg
    Sponsors:   Stanford University;   Santen Inc.
    Recruiting

  • Condition:   Uveitis
    Intervention:   Device: hand-held swept source optical coherence tomography
    Sponsor:   Duke University
    Recruiting

  • Condition:   Diabetic Macular Edema, Cystoid Macular Edema, Chorodial Neovascularzation, Posterior Uveitis
    Intervention:   Procedure: Custom suorachoroidal needle
    Sponsor:   Marashi Eye Clinic
    Recruiting

  • Condition:   Non-infectious Uveitis
    Intervention:   Biological: pEYS606
    Sponsor:   EYEVENSYS S.A.S.
    Recruiting

  • Conditions:   Uveitis;   Cataract;   Inflammation;   Posterior Capsule Opacification
    Interventions:   Device: Hydrophobic IOL: Vivinex (HOYA);   Device: Hydrophilic IOL: INCISE (Bausch+Lomb)
    Sponsor:   Vastra Gotaland Region
    Recruiting

  • Condition:   Patients With Newly Diagnosed Active NISU
    Interventions:   Drug: prednisone and ustekinumab treatment;   Other: Ophthalmologic examination;   Other: Questionnaires;   Biological: Blood samples
    Sponsor:   Centre Hospitalier Universitaire Dijon
    Not yet recruiting

  • Conditions:   Uveitis;   Age-Related Macular Degeneration
    Intervention:  
    Sponsor:   National Eye Institute (NEI)
    Recruiting

  • Conditions:   Uveitis;   Macular Edema
    Interventions:   Drug: Dexamethasone intravitreal implant 0.7 mg;   Drug: Intravitreal Methotrexate 400 µg;   Drug: Intravitreal Ranibizumab 0.5 mg
    Sponsors:   JHSPH Center for Clinical Trials;   National Eye Institute (NEI)
    Recruiting

  • Condition:   Cytomegalovirus Infections
    Intervention:   Drug: 2% guttae ganciclovir
    Sponsor:   Singapore National Eye Centre
    Recruiting

  • Conditions:   Uveitis;   Scleritis
    Intervention:   Drug: tofacitinib
    Sponsor:   Washington University School of Medicine
    Recruiting

  • Condition:   Proliferative Vitreoretinopathy
    Intervention:   Drug: Adrenocorticotropic Hormone
    Sponsors:   Johns Hopkins University;   Mallinckrodt
    Not yet recruiting

  • Conditions:   Ocular Sarcoidosis;   Panuveitis;   Anterior Uveitis
    Interventions:   Drug: Repository Corticotropin Injection;   Drug: Repository Corticotropin Injection -Treatment Extension
    Sponsors:   The Cleveland Clinic;   Mallinckrodt
    Recruiting

  • Conditions:   Conjunctivitis;   Glaucoma;   Myopia;   Diabetic Retinopathy;   Retinal Detachment;   Retinal Neovascularization, Unspecified;   Uveitis
    Intervention:   Diagnostic Test: OCTA (ZEISS)
    Sponsor:   Shanghai Eye Disease Prevention and Treatment Center
    Not yet recruiting

  • Conditions:   Autoimmune Diseases;   Inflammatory Bowel Diseases;   Crohn Disease (CD);   Colitis, Ulcerative (UC);   Arthritis, Rheumatoid (RA);   Spondylarthropathies;   Arthritis, Psoriatic (PsA);   Psoriasis;   Hidradenitis Suppurativa (HS);   Uveitis
    Interventions:   Other: Primary exposure variable;   Other: Other (exploratory) exposure variables
    Sponsors:   University of Southern Denmark;   Hospital of Southern Jutland;   University Hospital Bispebjerg and Frederiksberg;   University of Copenhagen;   Odense University Hospital;   University of Aarhus;   Aalborg Universitetshospital;   Herning Hospital;   Hospital of South West Jutland;   Sygehus Lillebaelt;   Aalborg University;   University of Kiel;   Colitis-Crohn Foreningen;   Herlev Hospital;   Regionshospitalet Silkeborg;   Aarhus University Hospital;   The Danish Psoriasis Association
    Recruiting

  • Condition:   Juvenile Idiopathic Arthritis
    Interventions:   Drug: Abatacept Injection;   Other: Usual Care
    Sponsor:   Duke University
    Not yet recruiting

  • Condition:   Behçet Disease Affecting Oral Mucosa
    Interventions:   Drug: Pentoxifylline;   Drug: Colchicine
    Sponsors:   Ipekyolu Ilac Ltd. Sti;   Istanbul University-Cerrahpasa School of Medicine
    Not yet recruiting

  • Condition:   Behçet
    Intervention:   Diagnostic Test: measurement of serum endocan
    Sponsor:   Benha University
    Recruiting

  • Condition:   Behçet Disease
    Intervention:   Other: Study group
    Sponsor:   Gazi University
    Recruiting

  • Conditions:   Behçet Disease;   Behcet's Disease Aggravated
    Intervention:   Other: Behçet's disease Overall Damage Index (BODI)
    Sponsor:   University of Cagliari
    Recruiting

  • Conditions:   Autoimmune;   Behcet Syndrome
    Interventions:   Radiation: Diode laser 980nm&100 mWatt;   Drug: Triamcinolone Acetonide
    Sponsor:   Cairo University
    Not yet recruiting

  • Condition:   Behcet Syndrome
    Intervention:   Diagnostic Test: blood samples
    Sponsor:   Assiut University
    Not yet recruiting

  • Condition:   Behcet's Disease
    Intervention:   Drug: GSK1070806
    Sponsor:   Cambridge University Hospitals NHS Foundation Trust
    Not yet recruiting

  • Condition:   Behcet Disease
    Intervention:   Drug: drug administration
    Sponsor:   Novartis Pharmaceuticals
    Recruiting

  • Conditions:   Retinal Vasculitis;   Behcet Syndrome
    Intervention:  
    Sponsor:   Assiut University
    Recruiting

  • Conditions:   Behcet's Disease;   Central Sensitisation
    Interventions:   Diagnostic Test: Central sensitisation;   Diagnostic Test: Neuropathic pain;   Other: Sleep disturbance;   Other: Quality of life
    Sponsor:   Bursa Yüksek İhtisas Education and Research Hospital
    Recruiting

  • Conditions:   Fibromyalgia;   Behcet Syndrome
    Interventions:   Diagnostic Test: group 1:Patients diagnosed with Behcet disease;   Diagnostic Test: group 2: Patient diagnosed with fibromyalgia without Behcet disease
    Sponsor:   Bursa Yüksek İhtisas Education and Research Hospital
    Recruiting

  • Conditions:   Vasculitis;   Behcet's Disease;   CNS Vasculitis;   Cryoglobulinemic Vasculitis;   Eosinophilic Granulomatosis With Polyangiitis (EGPA);   Churg-Strauss Syndrome (CSS);   Granulomatosis With Polyangiitis (GPA);   Wegener's Granulomatosis;   IgA Vasculitis;   Henoch-Schoenlein Purpura (HSP);   Microscopic Polyangiitis (MPA);   Polyarteritis Nodosa (PAN);   Takayasu Arteritis (TAK);   Urticarial Vasculitis;   Systemic Vasculitis
    Intervention:   Other: Online questionnaires
    Sponsors:   University of Pennsylvania;   Duke University;   University of South Florida
    Recruiting

  • Conditions:   Rheumatoid Arthritis;   Ankylosing Spondylitis;   Systemic Lupus Erythematosus;   Psoriasis;   Behcet's Disease;   Wegener's Granulomatosis;   Takayasu's Disease;   Crohn's Disease;   Ulcerative Colitis;   Autoimmune Hepatitis;   Sclerosing Cholangitis;   Gougerot-sjögren;   Idiopathic Thrombocytopenic Purpura;   Systemic Sclerosis
    Intervention:   Drug: Interleukin 2
    Sponsors:   Assistance Publique - Hôpitaux de Paris;   Iltoo Pharma
    Recruiting

  • Conditions:   Rare Disorders;   Undiagnosed Disorders;   Disorders of Unknown Prevalence;   Cornelia De Lange Syndrome;   Prenatal Benign Hypophosphatasia;   Perinatal Lethal Hypophosphatasia;   Odontohypophosphatasia;   Adult Hypophosphatasia;   Childhood-onset Hypophosphatasia;   Infantile Hypophosphatasia;   Hypophosphatasia;   Kabuki Syndrome;   Bohring-Opitz Syndrome;   Narcolepsy Without Cataplexy;   Narcolepsy-cataplexy;   Hypersomnolence Disorder;   Idiopathic Hypersomnia Without Long Sleep Time;   Idiopathic Hypersomnia With Long Sleep Time;   Idiopathic Hypersomnia;   Kleine-Levin Syndrome;   Kawasaki Disease;   Leiomyosarcoma;   Leiomyosarcoma of the Corpus Uteri;   Leiomyosarcoma of the Cervix Uteri;   Leiomyosarcoma of Small Intestine;   Acquired Myasthenia Gravis;   Addison Disease;   Hyperacusis (Hyperacousis);   Juvenile Myasthenia Gravis;   Transient Neonatal Myasthenia Gravis;   Williams Syndrome;   Lyme Disease;   Myasthenia Gravis;   Marinesco Sjogren Syndrome(Marinesco-Sjogren Syndrome);   Isolated Klippel-Feil Syndrome;   Frasier Syndrome;   Denys-Drash Syndrome;   Beckwith-Wiedemann Syndrome;   Emanuel Syndrome;   Isolated Aniridia;   Beckwith-Wiedemann Syndrome Due to Paternal Uniparental Disomy of Chromosome 11;   Beckwith-Wiedemann Syndrome Due to Imprinting Defect of 11p15;   Beckwith-Wiedemann Syndrome Due to 11p15 Translocation/Inversion;   Beckwith-Wiedemann Syndrome Due to 11p15 Microduplication;   Beckwith-Wiedemann Syndrome Due to 11p15 Microdeletion;   Axenfeld-Rieger Syndrome;   Aniridia-intellectual Disability Syndrome;   Aniridia - Renal Agenesis - Psychomotor Retardation;   Aniridia - Ptosis - Intellectual Disability - Familial Obesity;   Aniridia - Cerebellar Ataxia - Intellectual Disability;   Aniridia - Absent Patella;   Aniridia;   Peters Anomaly - Cataract;   Peters Anomaly;   Potocki-Shaffer Syndrome;   Silver-Russell Syndrome Due to Maternal Uniparental Disomy of Chromosome 11;   Silver-Russell Syndrome Due to Imprinting Defect of 11p15;   Silver-Russell Syndrome Due to 11p15 Microduplication;   Syndromic Aniridia;   WAGR Syndrome;   Wolf-Hirschhorn Syndrome;   4p16.3 Microduplication Syndrome;   4p Deletion Syndrome, Non-Wolf-Hirschhorn Syndrome;   Autosomal Recessive Stickler Syndrome;   Stickler Syndrome Type 2;   Stickler Syndrome Type 1;   Stickler Syndrome;   Mucolipidosis Type 4;   X-linked Spinocerebellar Ataxia Type 4;   X-linked Spinocerebellar Ataxia Type 3;   X-linked Intellectual Disability - Ataxia - Apraxia;   X-linked Progressive Cerebellar Ataxia;   X-linked Non Progressive Cerebellar Ataxia;   X-linked Cerebellar Ataxia;   Vitamin B12 Deficiency Ataxia;   Toxic Exposure Ataxia;   Unclassified Autosomal Dominant Spinocerebellar Ataxia;   Thyroid Antibody Ataxia;   Sporadic Adult-onset Ataxia of Unknown Etiology;   Spinocerebellar Ataxia With Oculomotor Anomaly;   Spinocerebellar Ataxia With Epilepsy;   Spinocerebellar Ataxia With Axonal Neuropathy Type 2;   Spinocerebellar Ataxia Type 8;   Spinocerebellar Ataxia Type 7;   Spinocerebellar Ataxia Type 6;   Spinocerebellar Ataxia Type 5;   Spinocerebellar Ataxia Type 4;   Spinocerebellar Ataxia Type 37;   Spinocerebellar Ataxia Type 36;   Spinocerebellar Ataxia Type 35;   Spinocerebellar Ataxia Type 34;   Spinocerebellar Ataxia Type 32;   Spinocerebellar Ataxia Type 31;   Spinocerebellar Ataxia Type 30;   Spinocerebellar Ataxia Type 3;   Spinocerebellar Ataxia Type 29;   Spinocerebellar Ataxia Type 28;   Spinocerebellar Ataxia Type 27;   Spinocerebellar Ataxia Type 26;   Spinocerebellar Ataxia Type 25;   Spinocerebellar Ataxia Type 23;   Spinocerebellar Ataxia Type 22;   Spinocerebellar Ataxia Type 21;   Spinocerebellar Ataxia Type 20;   Spinocerebellar Ataxia Type 2;   Spinocerebellar Ataxia Type 19/22;   Spinocerebellar Ataxia Type 18;   Spinocerebellar Ataxia Type 17;   Spinocerebellar Ataxia Type 16;   Spinocerebellar Ataxia Type 15/16;   Spinocerebellar Ataxia Type 14;   Spinocerebellar Ataxia Type 13;   Spinocerebellar Ataxia Type 12;   Spinocerebellar Ataxia Type 11;   Spinocerebellar Ataxia Type 10;   Spinocerebellar Ataxia Type 1 With Axonal Neuropathy;   Spinocerebellar Ataxia Type 1;   Spinocerebellar Ataxia - Unknown;   Spinocerebellar Ataxia - Dysmorphism;   Non Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature;   Spectrin-associated Autosomal Recessive Cerebellar Ataxia;   Spasticity-ataxia-gait Anomalies Syndrome;   Spastic Ataxia With Congenital Miosis;   Spastic Ataxia - Corneal Dystrophy;   Spastic Ataxia;   Rare Hereditary Ataxia;   Rare Ataxia;   Recessive Mitochondrial Ataxia Syndrome;   Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature;   Posterior Column Ataxia - Retinitis Pigmentosa;   Post-Stroke Ataxia;   Post-Head Injury Ataxia;   Post Vaccination Ataxia;   Polyneuropathy - Hearing Loss - Ataxia - Retinitis Pigmentosa - Cataract;   Muscular Atrophy - Ataxia - Retinitis Pigmentosa - Diabetes Mellitus;   Non-progressive Cerebellar Ataxia With Intellectual Disability;   Non-hereditary Degenerative Ataxia;   Paroxysmal Dystonic Choreathetosis With Episodic Ataxia and Spasticity;   Olivopontocerebellar Atrophy - Deafness;   NARP Syndrome;   Myoclonus - Cerebellar Ataxia - Deafness;   Multiple System Atrophy, Parkinsonian Type;   Multiple System Atrophy, Cerebellar Type;   Multiple System Atrophy;   Maternally-inherited Leigh Syndrome;   Machado-Joseph Disease Type 3;   Machado-Joseph Disease Type 2;   Machado-Joseph Disease Type 1;   Lethal Ataxia With Deafness and Optic Atrophy;   Leigh Syndrome;   Leukoencephalopathy With Mild Cerebellar Ataxia and White Matter Edema;   Leukoencephalopathy - Ataxia - Hypodontia - Hypomyelination;   Leigh Syndrome With Nephrotic Syndrome;   Leigh Syndrome With Leukodystrophy;   Leigh Syndrome With Cardiomyopathy;   Late-onset Ataxia With Dementia;   Intellectual Disability-hyperkinetic Movement-truncal Ataxia Syndrome;   Infection or Post Infection Ataxia;   Infantile-onset Autosomal Recessive Nonprogressive Cerebellar Ataxia;   Infantile Onset Spinocerebellar Ataxia;   GAD Ataxia;   Hereditary Episodic Ataxia;   Gliadin/Gluten Ataxia;   Friedreich Ataxia;   Fragile X-associated Tremor/Ataxia Syndrome;   Familial Paroxysmal Ataxia;   Exposure to Medications Ataxia;   Episodic Ataxia With Slurred Speech;   Episodic Ataxia Unknown Type;   Episodic Ataxia Type 7;   Episodic Ataxia Type 6;   Episodic Ataxia Type 5;   Episodic Ataxia Type 4;   Episodic Ataxia Type 3;   Episodic Ataxia Type 1;   Epilepsy and/or Ataxia With Myoclonus as Major Feature;   Early-onset Spastic Ataxia-neuropathy Syndrome;   Early-onset Progressive Neurodegeneration - Blindness - Ataxia - Spasticity;   Early-onset Cerebellar Ataxia With Retained Tendon Reflexes;   Early-onset Ataxia With Dementia;   Childhood-onset Autosomal Recessive Slowly Progressive Spinocerebellar Ataxia;   Dilated Cardiomyopathy With Ataxia;   Cataract - Ataxia - Deafness;   Cerebellar Ataxia, Cayman Type;   Cerebellar Ataxia With Peripheral Neuropathy;   Cerebellar Ataxia - Hypogonadism;   Cerebellar Ataxia - Ectodermal Dysplasia;   Cerebellar Ataxia - Areflexia - Pes Cavus - Optic Atrophy - Sensorineural Hearing Loss;   Brain Tumor Ataxia;   Brachydactyly - Nystagmus - Cerebellar Ataxia;   Benign Paroxysmal Tonic Upgaze of Childhood With Ataxia;   Autosomal Recessive Syndromic Cerebellar Ataxia;   Autosomal Recessive Spastic Ataxia With Leukoencephalopathy;   Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay;   Autosomal Recessive Spastic Ataxia - Optic Atrophy - Dysarthria;   Autosomal Recessive Spastic Ataxia;   Autosomal Recessive Metabolic Cerebellar Ataxia;   Autosomal Dominant Spinocerebellar Ataxia Due to Repeat Expansions That do Not Encode Polyglutamine;   Autosomal Recessive Ataxia, Beauce Type;   Autosomal Recessive Ataxia Due to Ubiquinone Deficiency;   Autosomal Recessive Ataxia Due to PEX10 Deficiency;   Autosomal Recessive Degenerative and Progressive Cerebellar Ataxia;   Autosomal Recessive Congenital Cerebellar Ataxia Due to MGLUR1 Deficiency;   Autosomal Recessive Congenital Cerebellar Ataxia Due to GRID2 Deficiency;   Autosomal Recessive Congenital Cerebellar Ataxia;   Autosomal Recessive Cerebellar Ataxia-pyramidal Signs-nystagmus-oculomotor Apraxia Syndrome;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to WWOX Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to TUD Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to KIAA0226 Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome;   Autosomal Recessive Cerebellar Ataxia With Late-onset Spasticity;   Autosomal Recessive Cerebellar Ataxia Due to STUB1 Deficiency;   Autosomal Recessive Cerebellar Ataxia Due to a DNA Repair Defect;   Autosomal Recessive Cerebellar Ataxia - Saccadic Intrusion;   Autosomal Recessive Cerebellar Ataxia - Psychomotor Retardation;   Autosomal Recessive Cerebellar Ataxia - Blindness - Deafness;   Autosomal Recessive Cerebellar Ataxia;   Autosomal Dominant Spinocerebellar Ataxia Due to a Polyglutamine Anomaly;   Autosomal Dominant Spinocerebellar Ataxia Due to a Point Mutation;   Autosomal Dominant Spinocerebellar Ataxia Due to a Channelopathy;   Autosomal Dominant Spastic Ataxia Type 1;   Autosomal Dominant Spastic Ataxia;   Autosomal Dominant Optic Atrophy;   Ataxia-telangiectasia Variant;   Ataxia-telangiectasia;   Autosomal Dominant Cerebellar Ataxia, Deafness and Narcolepsy;   Autosomal Dominant Cerebellar Ataxia Type 4;   Autosomal Dominant Cerebellar Ataxia Type 3;   Autosomal Dominant Cerebellar Ataxia Type 2;   Autosomal Dominant Cerebellar Ataxia Type 1;   Autosomal Dominant Cerebellar Ataxia;   Ataxia-telangiectasia-like Disorder;   Ataxia-intellectual Disability-oculomotor Apraxia-cerebellar Cysts Syndrome;   Ataxia-deafness-intellectual Disability Syndrome;   Ataxia With Vitamin E Deficiency;   Ataxia With Dementia;   Ataxia Neuropathy Spectrum;   Ataxia - Tapetoretinal Degeneration;   Ataxia - Photosensitivity - Short Stature;   Ataxia - Pancytopenia;   Ataxia - Oculomotor Apraxia Type 1;   Ataxia - Hypogonadism - Choroidal Dystrophy;   Ataxia - Other;   Ataxia - Genetic Diagnosis - Unknown;   Acquired Ataxia;   Adult-onset Autosomal Recessive Cerebellar Ataxia;   Alcohol Related Ataxia;   Multiple Endocrine Neoplasia;   Multiple Endocrine Neoplasia Type II;   Multiple Endocrine Neoplasia Type 1;   Multiple Endocrine Neoplasia Type 2;   Multiple Endocrine Neoplasia, Type IV;   Multiple Endocrine Neoplasia, Type 3;   Multiple Endocrine Neoplasia (MEN) Syndrome;   Multiple Endocrine Neoplasia Type 2B;   Multiple Endocrine Neoplasia Type 2A;   Atypical Hemolytic Uremic Syndrome;   Atypical HUS;   Wiedemann-Steiner Syndrome;   Breast Implant-Associated Anaplastic Large Cell Lymphoma;   Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA);   Hemophagocytic Lymphohistiocytosis;   Behcet's Disease;   Alagille Syndrome;   Inclusion Body Myopathy With Early-onset Paget Disease and Frontotemporal Dementia (IBMPFD);   Lowe Syndrome;   Pitt Hopkins Syndrome;   1p36 Deletion Syndrome;   Jansen Type Metaphyseal Chondrodysplasia;   Cockayne Syndrome;   Chronic Recurrent Multifocal Osteomyelitis;   CRMO;   Malan Syndrome;   Hereditary Sensory and Autonomic Neuropathy Type Ie
    Intervention:  
    Sponsors:   Sanford Health;   National Ataxia Foundation;   International WAGR Syndrome Association;   4p- Support Group;   ML4 Foundation;   Cornelia de Lange Syndrome Foundation;   Stickler Involved People;   Kawasaki Disease Foundation;   Klippel-Feil Syndrome Alliance;   Klippel-Feil Syndrome Freedom;   Hyperacusis Research Limited;   Hypersomnia Foundation;   Kabuki Syndrome Network;   Kleine-Levin Syndrome Foundation;   Leiomyosarcoma Direct Research Foundation;   Marinesco-Sjogren Syndrome Support Group;   Mucolipidosis Type IV (ML4) Foundation;   People with Narcolepsy 4 People with Narcolepsy (PWN4PWN);   Soft Bones Incorporated;   American Multiple Endocrine Neoplasia Support;   Atypical Hemolytic Uremic Syndrome Foundation;   All Things Kabuki;   Wiedemann-Steiner Syndrome Foundation;   Breast Implant Victim Advocates;   PROS Foundation;   American Behcet's Disease Association
    Recruiting